In addition, Rab10 phosphorylation has been shown to be increased in the brains of sporadic PD patients [162], suggesting that reducing substrate phosphorylation of LRRK2 may also be beneficial for sporadic PD patients. This evidence concerns the gene LRRK2 and Parkinson disease.